Fifth Third Bancorp’s Lexicon Pharmaceuticals LXRX Stock Holding History

Fifth Third Bancorp’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-800	Closed	-$2K	–	2283
2019 Q3	$2K	Buy	+800	New	+$2.48K	﹤0.01%	2054

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Fifth Third Bancorp's LXRX Position: Q4 2019 in Review

Fifth Third Bancorp sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2019, closing a stake of 800 shares — an estimated $2K sold.

Fifth Third Bancorp first reported a position in LXRX in Q3 2019 and held it in 1 quarter. The position peaked at $2K in Q3 2019. 115 funds tracked by Wall St. Rank hold LXRX as of Q4 2019.

Fifth Third Bancorp reported no remaining Lexicon Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Fifth Third Bancorp sold 800 Lexicon Pharmaceuticals shares in Q4 2019, an estimated $2K.
Fifth Third Bancorp first reported a position in Lexicon Pharmaceuticals in Q3 2019 and held it in 1 quarter.
Fifth Third Bancorp's Lexicon Pharmaceuticals position peaked at $2K in Q3 2019.
115 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2019.

Based on Fifth Third Bancorp's 13F filing for Q4 2019, filed 14 Feb 2020.